CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

WOC Pharma and Healthcare Fund-Reg(G)

very highequitypharma & health care
13.92 0.01(0.07%) NAV as on 12 Dec 2025
-1.63 % 1 M
4.24 % 1 Y
NA 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.38

As on 30 Nov, 2025
age-icon Age :

1 yrs 10 m

Since 06 02 ,2024
exit_load Exit Load :

1%

aum AUM :

501.89 Crs

lock_in Lock-in :

1% on or before 1M, Nil after 1M

investing_style Investing Style :

Mid Growth

Portfolio_book_value Portfolio Price To Book Value :

9.45

Min_Investment Min. Investment :

SIP 100 & Lumpsum 500

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Ramesh Mantri,Dheeresh Pathak,Piyush Baranwal

LATEST ASSET & PORTFOLIO ALLOCATION

as on Nov 30 ,2025
Debt 4.08 %
Others 6.05 %
Equity 89.86 %

TOP HOLDINGS

Sun Pharmaceutical Industries...8.31 %
JB Chemicals & Pharmaceuticals...7.29 %
Max Healthcare Institute Ltd.6.81 %
Fortis Healthcare Ltd.5.53 %
Laurus Labs Ltd.4.94 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs59.03
Hospital & Healthcare Services25.57
Plastic Products2.10
Chemicals1.92
Medical Equipment/Supplies/Accessories1.24
See All Sectors

5-YEARS HISTORY

Financial Year2023-20242024-2025
NAV in Rs (as on 31-Mar-2025)9.9612.74
Net Assets(Rs Crores) (as on 31-Mar-2025) 108.61 303.62
Scheme Returns(%)(Absolute)-0.4426.85
B'mark Returns(%)(Absolute)NANA
Category Rank85/902/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

WOC Pharma and Healthcare Fund-Reg(G)Very HighEquity13.920.01(0.07%)NAV As on 12 Dec, 202506-Feb-2024Inception Date501.89AUM In Cr.4.24%1YNA%3YNA%5Y19.57%Since Inception
UTI Healthcare Fund-Reg(G)Very HighEquity286.231.60(0.56%)NAV As on 12 Dec, 202501-Aug-2005Inception Date1,126.13AUM In Cr.-1.23%1Y23.83%3Y15.73%5Y17.89%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity30.430.02(0.06%)NAV As on 12 Dec, 202528-Dec-2015Inception Date1,338.85AUM In Cr.-0.19%1Y21.93%3Y15.94%5Y11.82%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.